Workboat Indexes
Century Therapeutics Inc (NQ: IPSC )
1.570
+0.030
(+1.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 10, 2024
Add to My Watchlist
All News about Century Therapeutics Inc
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](/next-assets/images/schema-image-default.png)
Century Therapeutics: Q1 Earnings Insights
May 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_6626.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Century Therapeutics
April 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Century Therapeutics's Return On Capital Employed Overview
March 20, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/28/workday_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Century Therapeutics Stands With Analysts
March 16, 2023
Via Benzinga
8 Analysts Have This to Say About Century Therapeutics
January 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/10/century_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
Century Therapeutics Announces Leadership Changes
April 12, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
Century Therapeutics to Present at Upcoming Investor Conferences
February 21, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
Century Therapeutics to Present at Upcoming Investor Conferences
February 01, 2023
Via GlobeNewswire
![](https://www.marketbeat.com/logos/articles/small_stock-image_180756848_S.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1290.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image19.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_857.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Thursday
January 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/10/image29.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/group-1.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.